Newsletters

Philips, Quibim integrate for AI-powered prostate cancer diagnosis

Key Insights and Signals – Hospital & Healthcare

Partnership
Philips, Quibim integrate for AI-powered prostate cancer diagnosis
Philips and Quibim are partnering to develop an AI-powered care management platform for prostate cancer diagnosis. The platform aims to automate MRI prostate gland segmentation, standardize reporting, and enhance diagnostic accuracy. Read More>>
Pramana and Techcyte partner for digital diagnostics technology
Pramana partners with Techcyte to boost microbiology and cytology diagnostics with AI-driven imaging. This collaboration covers tech development, regulations, sales, and global distribution. Read More>>


Centre Setup and Expansion
Texas Oncology debuts new Cancer Center in Beaumont
Texas Oncology opened a 32,000-square-foot cancer care center on the CHRISTUS Southeast Texas St. Elizabeth campus in Beaumont, offering medical oncology, radiation oncology, chemotherapy, and clinical trials, along with a range of services. The center features advanced treatment equipment and an on-site pharmacy. Read More>>


Merger and Acquisition
PicnicHealth acquires AllStripes
PicnicHealth has acquired AllStripes, bolstering its patient-centered healthcare evidence-generation capabilities. This acquisition expands the company’s reach and strengthens its evidence-generation solutions, particularly in the rare disease community. Read More>>


Executive Movement
Recuro Health appoints Jason Casten as its new CFO
Jason brings over two decades of healthcare technology leadership and financial expertise, notably as former CFO of MDLIVE and private equity experience. Read More>>

Key Insights and Signals in Medical Devices

Partnerships
US Med-Equip and Mindray partner to provide Medical Equipment Rentals
They joined forces to meet hospital demand for patient monitoring, anesthesia, and ultrasound solutions. Aiming to provide innovative solutions and top-quality equipment to enhance patient care. Read More>>
GE HealthCare and reLink Medical collaborate to help reduce Medical Device Waste for healthcare providers
They aim to offer asset management solutions, helping healthcare providers manage end-of-life medical equipment, reduce waste, and increase operational efficiency. Read More>>


Centre Setup and Expansion
Bayer opens cell therapy facility in Berkeley
Bayer has unveiled a USD 250 million cell therapy facility in Berkeley. The 100,000-square-foot facility will conduct clinical and commercial manufacturing for various treatments, including those for Parkinson’s disease. Read More>>


Merger and Acquisition
Laborie Medical Technologies acquires Urotronic
Laborie Medical Technologies has successfully acquired Urotronic, which developed Optilume drug-coated balloon technology for treating urethral strictures and BPH. Urotronic is now part of Laborie’s interventional urology efforts. Read More>>


Executive Movement
Radiaction Medical appoints Christopher Barys as the new US President and Chief Commercial Officer
Barys, an industry veteran, brings extensive experience in the interventional space to lead the company’s commercialization efforts and operations in the US. Radiaction is focused on expanding its radiation protection solution in the United States. Read More>>

Key Insights and Signals in Pharmaceutical

Partnership
Henlius deepens collaboration with Intas Pharmaceuticals
The companies partnered for the development and commercialization of serplulimab injection in Europe and India for multiple indications. The agreement includes an upfront payment of USD 44.6 million, regulatory and commercial milestones, and royalties on net profit for Henlius. Read More>>


Center Setup and Expansion
Quotient Sciences adds drug development at UK plant
Quotient Sciences is enhancing its UK facility in Alnwick with two grade C cleanrooms for sterile manufacturing in drug development. They’ve invested in isolator tech for efficiency, and clinical batches start in December 2023. Read More>>
Cytiva amps up regional manufacturing strategy with India plant
Cytiva has opened a 33,000 sqft facility and Experience Center in Pune, India, for bioprocessing equipment production. It offers training programs and digital tools and showcases products like ÄKTA, Allegro, iCELLis, and Sepax. Read More>>


Merger and Acquisition
Amgen buys Horizon Therapeutics for USD 27.8 Bn
Amgen has completed its USD 27.8 billion acquisition of Horizon Therapeutics after the US Federal Trade Commission withdrew its legal challenge. Horizon focuses on treating rare autoimmune and inflammatory diseases. The acquisition aims to strengthen Amgen’s position across a broader range of diseases. Read More>>


Executive Movement
Quotient Sciences appoints Thierry Van Nieuwenhove as new CEO
Van Nieuwenhove brings over 23 years of pharma/CDMO experience, including roles at ABL Inc., Novasep, Lonza, and Minakem. Wayne Hewett, with extensive board and leadership experience, has been appointed as the Non-Executive Chairman. Read More>>

Latest Industry Insights from Draup Braindesk

Inflammatory Disease Advancements
  • Pfizer aims to combat the foremost global cause of death, cardiovascular disease, by developing therapies that address its underlying factors, including metabolic abnormalities while enhancing patients’ well-being.  
  • The company enhances patient outcomes by leading advancements in the management of inflammatory and autoimmune diseases, aiming for safer and more effective treatments.
Disease Control Initiatives
  • Pfizer prioritizes developing vaccines, eradicating diseases such as polio, and innovating solutions to combat deadly pathogens, safeguarding public health across all age groups.  
  • The company emphasizes cancer research, with notable progress in breast cancer treatment, while addressing infectious diseases and the pressing concern of Antimicrobial Resistance (AMR).  
  • Pfizer offers patients information, resources, and connections to healthcare professionals and medication reminders to improve healthcare accessibility.

Key Funding Alert

Selkirk Pharma raises USD 24 Mn in seed funding
Selkirk Pharma Inc., a Spokane-based injectable drug manufacturer, raised USD 24.1 million in seed funding, valuing it at USD 375 million. They’ll expand their facilities, employing 750 professionals focusing on cutting-edge technology in the Spokane pharmaceutical hub. Read More>>

Startup Spotlight

Company – Frontier Direct Care
Total Funding USD 4.92 Mn
About: Frontier Direct Care is a membership to a team of local doctors and clinics. It offers a monthly subscription to family a doctor with no wait times, no insurance hassle, and no hidden costs. Read More>>

Latest Reports Published in Draup

Johnson & Johnson Services, Inc. Account Intelligence Report
Johnson & Johnson uses AI in healthcare, especially in drug discovery, to advance medical solutions through innovation. Read More>>

Here’s what’s new on our Sales Intelligence Platform
Easily track key executive movements for an executives list on your Homepage

  • Stay informed about significant executive movements in the companies added to ‘My Accounts’ and the executives added to ‘My Leads,’ all conveniently accessible from your homepage feed.

View All Updates

Twitter

LinkedIn

Copyright © *|CURRENT_YEAR|* Draup, All rights reserved.
*|IFNOT:ARCHIVE_PAGE|* *|LIST:DESCRIPTION|*

We are located at: *|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

 

What you should do now

  1. Request a Demo and see how Draup can maximize the impact of your go-to-market teams with AI-driven sales intelligence.
  2. Read more free material about sales intelligence topics in our blog.
  3. If you know someone who’d enjoy this page, share it with them via email, LinkedIn, Twitter, or Facebook.